http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108947908-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-27 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-27 |
| filingDate | 2018-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108947908-B |
| titleOfInvention | New intermediate of brivaracetam with imidazole ring and synthesis method and application thereof |
| abstract | The invention discloses a new intermediate of brivaracetam with imidazole ring, a synthetic method and application thereof. The new intermediate of the brivaracetam has the structural formula The new intermediate of the invention, used for synthesizing the brivaracetam, has the following benefits: the raw materials are cheap and easy to obtain, the reaction route is short, the yield is high, and the impurities are few. Meanwhile, due to the introduction of carbonyl imidazole, the problems that HPLC (high performance liquid chromatography) can not be carried out in the reaction process and the purity of the intermediate can not be detected are solved. |
| priorityDate | 2018-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.